title: Pharmacotherapy for women's sexual dysfunction.
abstract: BACKGROUND
  Women's sexual function is known to be strongly influenced by mental health and relationship factors. Biological factors interrupting sexual function that might potentially be remedied by pharmacological agents are less clear.
  
  
  OBJECTIVE
  To examine the role of medications for women's sexual dysfunction.
  
  
  METHODS
  Searches were done using Medline, Embase, Lilacs and Pubmed databases.
  
  
  CONCLUSIONS
  Although drugs designed to boost initial sexual desire have been trialed, amelioration of reduced sexual arousability may be a more appropriate target. There is limited evidence of pharmacological benefit to arousability so far. Local oestrogen therapy benefits reduced genital vasocongestion from vulvar vaginal atrophy. Drugs acting to enhance the actions of nitric oxide or vasoactive intestinal polypeptide can only benefit reduced genital congestion: most women complaining of low arousal have normal genital vasocongestion in response to sexual stimulation. In the context of autonomic neuropathies, phosphodiesterase inhibitors may be indicated. Early results of sexual benefit from local administration of dihydroepiandrosterone allowing intracellular production of oestrogen and testosterone in genital tissues post menopause seem promising.
authors.affiliation: UBC Department of Psychiatry, B.C. Centre for Sexual Medicine, Vancouver General Hospital, 855 West 12th Avenue, Vancouver, BC, Canada. Rosemary.Basson@vch.ca
authors.forename: Rosemary
authors.initials: R
authors.lastname: Basson
mesh_terms: D001143:Arousal / Q000187:drug effects*; D004967:Estrogens / Q000627:therapeutic use*; D005260:Female; D005831:Genital Diseases, Female / Q000188:drug therapy; D006801:Humans; D007989:Libido / Q000187:drug effects* / Q000502:physiology; D008297:Male; D017698:Postmenopause / Q000502:physiology*; D012725:Sexual Behavior / Q000187:drug effects; D012735:Sexual Dysfunction, Physiological / Q000188:drug therapy; D020018:Sexual Dysfunctions, Psychological / Q000188:drug therapy*; D013739:Testosterone / Q000627:therapeutic use*; D014481:United States; D014621:Vagina / Q000187:drug effects* / Q000502:physiology; D016387:Women's Health
chemical_list: D004967:Estrogens; D013739:Testosterone